Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT07264920
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chronic Pain
  • Neuropathic Pain

Eligibility Criteria

Sex
ALL
Age
5 Years - 26 Years
Healthy Volunteers
Not accepted

Interventions

  • Scrambler Therapy MC-5A Device — DEVICE
    Scrambler Therapy is a non-invasive electrocutaneous analgesia technique used to treat neuropathic pain. Each session lasts approximately 30-45 minutes and involves placing surface electrodes near the pain site to deliver low-level electrical signals that "scramble" pain messages into non-painful sensations. Pain intensity will be measured before and after each session.

Study Details

This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.

Key Dates

Start date
Aug 31, 2026
Status verified
Jun 2026
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
70 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment - Scrambler Therapy MC-5A Device
    Surface electrodes will be placed near the pain site to deliver low-level electrical signals that "scramble" pain messages into non-painful sensations.

Primary Outcome Measure

Change in self-reported pain intensity as assessed by the Numerical Rating Scale or the Wong-Baker Faces Pain Scale [ Time Frame: Prior to first therapy session and immediately following last therapy session ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins Children's CenterBaltimoreMaryland21287
Joann Hunsberger, MD
[email protected]
410-955-2448
Colleen Mennie, RN, BSN
[email protected]
410-955-6412
Joann Hunsberger, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By research site
Johns Hopkins Children's Center· Baltimore, MD

Related Studies